201 related articles for article (PubMed ID: 29635010)
1. Dose-reduction antiangiogenic curcumin-low molecular weight heparin nanodrugs for enhanced combinational antitumor therapy.
Xiao Y; Xu C; Xiong H; Du S; Zhou J; Yin L; Yao J
Eur J Pharm Sci; 2018 Jul; 119():121-134. PubMed ID: 29635010
[TBL] [Abstract][Full Text] [Related]
2. pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release.
Xiong H; Wu Y; Jiang Z; Zhou J; Yang M; Yao J
J Colloid Interface Sci; 2019 Feb; 536():135-148. PubMed ID: 30366179
[TBL] [Abstract][Full Text] [Related]
3. Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy.
Li Y; Wu Y; Huang L; Miao L; Zhou J; Satterlee AB; Yao J
J Control Release; 2016 Apr; 228():107-119. PubMed ID: 26941036
[TBL] [Abstract][Full Text] [Related]
4. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation.
Hong J; Liu Y; Xiao Y; Yang X; Su W; Zhang M; Liao Y; Kuang H; Wang X
Drug Deliv; 2017 Nov; 24(1):109-120. PubMed ID: 28155567
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of intravenously injectable curcumin nanosuspension.
Gao Y; Li Z; Sun M; Guo C; Yu A; Xi Y; Cui J; Lou H; Zhai G
Drug Deliv; 2011 Feb; 18(2):131-42. PubMed ID: 20939679
[TBL] [Abstract][Full Text] [Related]
6. Development of a folate-modified curcumin loaded micelle delivery system for cancer targeting.
Yang C; Chen H; Zhao J; Pang X; Xi Y; Zhai G
Colloids Surf B Biointerfaces; 2014 Sep; 121():206-13. PubMed ID: 24984268
[TBL] [Abstract][Full Text] [Related]
7. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
8. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
11. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
Manju S; Sreenivasan K
J Colloid Interface Sci; 2012 Feb; 368(1):144-51. PubMed ID: 22200330
[TBL] [Abstract][Full Text] [Related]
12. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
[TBL] [Abstract][Full Text] [Related]
13. An α-tocopheryl succinate enzyme-based nanoassembly for cancer imaging and therapy.
Lee SY; Cho HJ
Drug Deliv; 2018 Nov; 25(1):738-749. PubMed ID: 29516756
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-Loaded TPGS/F127/P123 Mixed Polymeric Micelles for Cervical Cancer Therapy: Formulation, Characterization, and
Wang J; Liu Q; Yang L; Xia X; Zhu R; Chen S; Wang M; Cheng L; Wu X; Wang S
J Biomed Nanotechnol; 2017 Dec; 13(12):1631-1646. PubMed ID: 29490752
[TBL] [Abstract][Full Text] [Related]
15. Drug induced micellization into ultra-high capacity and stable curcumin nanoformulations: Physico-chemical characterization and evaluation in 2D and 3D in vitro models.
Lübtow MM; Nelke LC; Seifert J; Kühnemundt J; Sahay G; Dandekar G; Nietzer SL; Luxenhofer R
J Control Release; 2019 Jun; 303():162-180. PubMed ID: 30981815
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of Curcumin Micellar Nanoparticles with Enhanced Anti-Cancer Activity.
Lee WH; Bebawy M; Loo CY; Luk F; Mason RS; Rohanizadeh R
J Biomed Nanotechnol; 2015 Jun; 11(6):1093-105. PubMed ID: 26353597
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
Cui T; Zhang S; Sun H
Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
[TBL] [Abstract][Full Text] [Related]
18. Developing and Evaluating In Vitro Effect of Poly(Ethylene Glycol) Conjugated Curcumin on Human Cancer Cell Lines.
Tung BT; Hai NT; Son PK
Curr Drug Discov Technol; 2016; 13(4):254-266. PubMed ID: 27758710
[TBL] [Abstract][Full Text] [Related]
19. Pectin-decorated selenium nanoparticles as a nanocarrier of curcumin to achieve enhanced physicochemical and biological properties.
Wu Y; Liu H; Li Z; Huang D; Nong L; Ning Z; Hu Z; Xu C; Yan JK
IET Nanobiotechnol; 2019 Oct; 13(8):880-886. PubMed ID: 31625531
[TBL] [Abstract][Full Text] [Related]
20. Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles.
Gong C; Deng S; Wu Q; Xiang M; Wei X; Li L; Gao X; Wang B; Sun L; Chen Y; Li Y; Liu L; Qian Z; Wei Y
Biomaterials; 2013 Jan; 34(4):1413-32. PubMed ID: 23164423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
